8.3 Only Molecular structures & names

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/32

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

33 Terms

1
New cards
<p></p>

Norepinephrine (endogenous beta agonist)

2
New cards
<p></p>

Levalbuterol (SABA/ R isomer)

3
New cards
<p></p>

Albuterol (SABA/ S isomer)

4
New cards
<p></p>

Salmeterol (LABA)

5
New cards
<p>*Phenyl-OCH3</p>

*Phenyl-OCH3

Formoterol (LABA)

6
New cards
<p></p>

Vilanterol ( Ultra LABA)

Phenyl w/ chlorines

7
New cards
<p></p>

Olodaterol (Ultra-long Acting ß2 Agonists)

Main benzene ring attached to another ring

N substituent ends w/ benzene and ether

8
New cards
<p></p>

Indacaterol (Ultra-long Acting ß2 Agonists)

Benzene attached to another ring

N substituent ends with benzene and 2 CH3 group sticking out. Looks like a bug

9
New cards
<p></p>

Cortisone (prodrug of cortisol)

Oxygen on C11 and no double bond on C1

10
New cards
<p></p>

Cortisol (active form, endogenous agonist at GC & MC)

11
New cards
<p></p>

Aldosterone (endogenous MC agonist)

Ketone on 18

12
New cards
term image

Prednisone (prodrug)

Looks like Cortisol but has double bond on C1

11 ketone converted to alcohol by 11ß-HSD to give prednisolone

13
New cards
<p></p>

Prednisolone (oral corticosteroid)

14
New cards
<p></p>

Methylprednisolone (Oral corticosteroid w/ higher GC activity)

6a-Methyl decreases mineralocorticoid activity, also increases glucocorticoid activity

15
New cards
<p></p>

Beclomethasone diproproprionate (ICS, prodrug)

9a-Chloro increases both glucocorticoid and mineralocorticoid activity, 16ß-methyl decreases mineralocorticoid activity

-prefer high glucorcorticoid activity and low mineralocorticoid activity?

16
New cards
<p></p>

Fluticasone propionate (ICS)

9a-F increases both glucocorticoid and mineralocorticoid activity, 6a-F enhances only glucocorticoid activity

17
New cards
<p></p>

Fluticasone furoate (ICS)

9a-F increases both glucocorticoid and mineralocorticoid activity, 6a-F enhances only glucocorticoid activity

18
New cards
<p></p>

Mometasone furoate (ICS & Least systemic bioavailability of all ICS)

9a-Cl increases both glucocorticoid and  mineralocorticoid activity, 16a-methyl  decreases mineralocorticoid activity

19
New cards
<p></p>

Flunisolide (ICS - Acetonide)

6a-F increases glucocorticoid activity

20
New cards
<p></p>

Budesonide (ICS - Acetonide)

21
New cards
<p></p>

Ciclesonide (ICS - Ester & Acetal)

22
New cards
<p></p>

Acetylcholine (endogenous NT)

23
New cards
<p></p>

Ipratropium bromide (SAMA)

24
New cards
<p></p>

Tiotropium Bromide (LAMA)

Two sulfide rings

25
New cards
<p></p>

Umeclidinium bromide (LAMA)

replaced thienyl rings with phenyl rings

26
New cards
<p></p>

Aclidinium bromide (LAMA)

Rings has sulfide on it

Long N substituent

27
New cards
<p></p>

Glycopyrrolate (glycopyrronium bromide/ LAMA)

28
New cards
<p></p>

Revenefacin (LAMA)

29
New cards
<p></p>

Roflumilast (PDE4 inhibitor)

Triangle

30
New cards
<p></p>

Ensifentrine (PDE3 inhibitor)

31
New cards
<p></p>

Zileuton (Leukotriene modifier- Inhibits 5-lipoxygenase)

N-Hydroxyl group necessary for function

32
New cards
<p></p>

Montelukast (Leukotriene Receptor Antagonist)

33
New cards
<p></p>

Zafirlukast (Leukotriene Receptor Antagonist)